[1] Ahmad, A. (2019). Breast cancer statistics: recent trends. Breast cancer metastasis and drug resistance: challenges and progress, 1-7.
[2] Bourang, S., Noruzpour, M., Jahanbakhsh Godekahriz, S., Ebrahimi, H. A. C., Amani, A., Asghari Zakaria, R., & Yaghoubi, H. (2024). Application of nanoparticles in breast cancer treatment: a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(9), 6459-6505.
[3] Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022). Chemotherapy: a double-edged sword in cancer treatment. Cancer immunology, immunotherapy, 71(3), 507-526.
[4] Fadaka, A., Ajiboye, B., Ojo, O., Adewale, O., Olayide, I., & Emuowhochere, R. (2017). Biology of glucose metabolization in cancer cells. Journal of Oncological Sciences, 3(2), 45-51.
[5] Noruzpour, M., Zakaria, R. A., Zare, N., Bourang, S., Ebrahimi, H. A., & Granados-Principal, S. (2025). Delivery of Moringa oleifera extract via PLA-PEG-FA/chitosan-PLA NPs into breast cancer cell lines. BioNanoScience, 15(2), 287.
[6] Mosleh-Shirazi, S., Abbasi, M., reza Moaddeli, M., Vaez, A., Shafiee, M., Kasaee, S. R., ... & Hatam, S. (2022). Nanotechnology advances in the detection and treatment of cancer: an overview. Nanotheranostics, 6(4), 400.
[7] Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023). Polyethylenimine (PEI) in gene therapy: Current status and clinical applications. Journal of Controlled Release, 362, 667-691.
[8] Amani, A., Kabiri, T., Shafiee, S., & Hamidi, A. (2019). Preparation and characterization of PLA-PEG-PLA/PEI/DNA nanoparticles for improvement of transfection efficiency and controlled release of DNA in gene delivery systems. Iranian journal of pharmaceutical research: IJPR, 18(1), 125.
[9] Abebe, D. G., Kandil, R., Kraus, T., Elsayed, M., Merkel, O. M., & Fujiwara, T. (2015). Three‐layered biodegradable micelles prepared by two‐step self‐assembly of PLA‐PEI‐PLA and PLA‐PEG‐PLA triblock copolymers as efficient gene delivery system. Macromolecular bioscience, 15(5), 698-711.
[10] Wang, Z., Ye, Q., Yu, S., & Akhavan, B. (2023). Poly ethylene glycol (PEG)‐based hydrogels for drug delivery in cancer therapy: a comprehensive review. Advanced healthcare materials, 12(18), 2300105.
[11] Bourang, S., Noruzpour, M., Azizi, S., Yaghoubi, H., & Ebrahimi, H. A. (2024). Synthesis and in vitro characterization of PCL-PEG-HA/FeCo magnetic nanoparticles encapsulating curcumin and 5-FU. Nanomedicine Journal, 11(2).
[12] Ke, X., Shelton, L., Hu, Y., Zhu, Y., Chow, E., Tang, H., ... & Mao, H. Q. (2020). Surface-functionalized PEGylated nanoparticles deliver messenger RNA to pulmonary immune cells. ACS applied materials & interfaces, 12(32), 35835-35844.
[13] Mohajeri, S., Dashti, S., Noruzpour, M., Bourang, S., & Yaghoubi, H. (2025). Design and preparation of PLA-chitosan-PEG-glucose copolymer for combined delivery of Paclitaxel and siRNA. Discover Applied Sciences, 7(8), 801.
[14] Bourang, S., Asadian, S., Noruzpour, M., Mansuryar, A., Azizi, S., Ebrahimi, H. A., & Amani Hooshyar, V. (2024). PLA-HA/Fe3O4 magnetic nanoparticles loaded with curcumin: physicochemical characterization and toxicity evaluation in HCT116 colorectal cancer cells. Discover Applied Sciences, 6(4), 186.
[15] Bourang, S., Jahanbakhsh Godehkahriz, S., Noruzpour, M., Asghari Zakaria, R., & Granados-Principal, S. Anticancer properties of copolymer nanoparticles loaded with Foeniculum vulgare derivatives in Hs578T and SUM159 cancer cell lines. Cancer Nano. 2025; 16: 1–28.
[16] Narmani, A., Rezvani, M., Farhood, B., Darkhor, P., Mohammadnejad, J., Amini, B., ... & Abdi Goushbolagh, N. (2019). Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug development research, 80(4), 404-424.
[17] Ramalho, M. J., Alves, B., Andrade, S., Lima, J., Loureiro, J. A., & Pereira, M. C. (2024). Folic-acid-conjugated poly (lactic-co-glycolic acid) nanoparticles loaded with gallic acid induce glioblastoma cell death by reactive-oxygen-species-induced stress. Polymers, 16(15), 2161.
[18] Soltani, M., Ahmadzadeh, N., Nasiraei Haghighi, H., Khatamian, N., & Homayouni Tabrizi, M. (2025). Targeted cancer therapy potential of quercetin-conjugated with folic acid-modified nanocrystalline cellulose nanoparticles: a study on AGS and A2780 cell lines. BMC biotechnology, 25(1), 29.
[19] Rostami, N., Gomari, M. M., Abdouss, M., Moeinzadeh, A., Choupani, E., Davarnejad, R., ... & Bencherif, S. A. (2023). Synthesis and characterization of folic acid-functionalized DPLA-co-PEG nanomicelles for the targeted delivery of letrozole. ACS Applied Bio Materials, 6(5), 1806-1815.
[20] Hamimed, S., Jabberi, M., & Chatti, A. (2022). Nanotechnology in drug and gene delivery. Naunyn-schmiedeberg's Archives of Pharmacology, 395(7), 769-787.
[21] Lin, P. H., Huang, C., Hu, Y., Ramanujam, V. S., Lee, E. S., Singh, R., ... & Chew, S. Y. (2023). Neural cell membrane-coated DNA nanogels as a potential target-specific drug delivery tool for the central nervous system. Biomaterials, 302, 122325.
[22] Angusamy, A., Palanisamy, S., Ravi, S., Kumaresan, M., Mohandoss, S., You, S., & Ramar, M. (2025). Investigation of antioxidant, antibacterial, anticancer and wound healing properties of eco-friendly synthesized copper oxide nanoparticles from Plumeria rubra leaf extract. Bioprocess and Biosystems Engineering, 48(8), 1295-1310.
[23] Ahmadi-Nouraldinvand, F., Bourang, S., Azizi, S., Noori, M., Noruzpour, M., & Yaghoubi, H. (2024). Preparation and characterization of multi-target nanoparticles for co-drug delivery. Medicine in Drug Discovery, 21, 100177.
[24] Mohajeri, S., Yaghoubi, H., Bourang, S., & Noruzpour, M. (2025). Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedeberg's Archives of Pharmacology, 1-23.
[25] Noruzpour, M., Asghari, Z. R., Zare, N., Ebrahimi, H. A., Parsa, H., & Bourang, S. (2024). Investigating the anticancer properties of the essential oil and aqueous extract of Moringa oleifera and its biosynthesized metal nanoparticles on MCF-7 and BT-549 cell lines.
[26] Bourang, S., Jahanbakhsh Godehkahriz, S., Asghari Zakaria, R., Parsa, H., & Noruzpuor, M. (2024). Green synthesis of iron oxide, copper, zinc oxide and silver nanoparticles from aqueous extract of F. vulgare and evaluation of their structural and antimicrobial properties. Agricultural Biotechnology Journal, 16(3), 60-88.
[27] Mohajeri, S., Fathi Erdi, A., & Yaghoubi, H. (2026). Targeted gene delivery to MCF-7 cells via polyspermine-PEG-glucose/DNA nanoparticles: Preparation and characterization. Molecular Biotechnology, 68(3), 1470-1488.
[28] Zhang, H., Qin, Z., Shi, S., Li, Y., Song, Y., & Zhang, Y. (2024). Construction and Identification of Eukaryotic Expression Vector pEGFP‐N1‐MIC‐1 for Mouse MIC‐1 Gene and Its Effect on Gastric Cancer Cells. Analytical Cellular Pathology, 2024(1), 2165242.
[29] Antoniou, J., Liu, F., Majeed, H., Qi, J., Yokoyama, W., & Zhong, F. (2015). Physicochemical and morphological properties of size-controlled chitosan–tripolyphosphate nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 465, 137-146.
[30] Khalid, A., Ahmed, R. M., Taha, M., & Soliman, T. S. (2023). Fe3O4 nanoparticles and Fe3O4@ SiO2 core-shell: synthesize, structural, morphological, linear, and nonlinear optical properties. Journal of Alloys and Compounds, 947, 169639.
[31] Cai, X., Dou, R., Guo, C., Tang, J., Li, X., Chen, J., & Zhang, J. (2023). Cationic polymers as transfection reagents for nucleic acid delivery. Pharmaceutics, 15(5), 1502.
[32] Jia, W., Wu, Y., Xie, Y., Yu, M., & Chen, Y. (2025). Advanced polymeric nanoparticles for cancer immunotherapy: materials engineering, immunotherapeutic mechanism and clinical translation. Advanced Materials, 37(8), 2413603.
[33] Xu, L., Cao, Y., Xu, Y., Li, R., & Xu, X. (2024). Redox‐Responsive polymeric nanoparticle for nucleic acid delivery and cancer therapy: progress, opportunities, and challenges. Macromolecular bioscience, 24(3), 2300238.
[34] Liu, M., Chu, Y., Liu, H., Su, Y., Zhang, Q., Jiao, J., ... & Song, Y. (2019). Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights. Molecular pharmaceutics, 17(4), 1059-1070.
[35] Mansuryar, A., Bourang, S., Noruzpour, M., Ebrahimi, H. A., Amani, A., Granados-Principal, S., & Calahorra, J. (2025). The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line. DARU Journal of Pharmaceutical Sciences, 33(2), 27.
[36] Wang, C., Wang, Q., Wang, H., Li, Z., Chen, J., Zhang, Z., ... & Li, Z. (2023). Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy. Journal of Controlled Release, 353, 391-410.
[37] Qenawi, N., Aziz, A. E., Asmaa, M., Tawfik, W., & Elfeky, S. A. (2025). Innovative graphene oxide-folic acid-MoS2 nanocomposite for targeted near-infrared photothermal cancer therapy. Egyptian Journal of Chemistry, 68(11), 363-375.
[38] Komuro, H., Sasano, T., Horiuchi, N., Yamashita, K., & Nagai, A. (2019). The effect of glucose modification of hydroxyapatite nanoparticles on gene delivery. Journal of Biomedical Materials Research Part A, 107(1), 61-66.
